Evidence map›Paper›PMID 32719234›Full record

ArticleThe Indian journal of medical research2020

Trends & treatment outcomes of multidrug-resistant tuberculosis in Delhi, India (2009-2014): A retrospective record-based study.

Nandini Sharma, Ashwani Khanna, Shivani Chandra, Saurav Basu, Kamal K Chopra, Neeta Singla, Neeti Babbar, Charu Kohli

Abstract read
In one paragraph

Article in The Indian journal of medical research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Nandini SharmaDepartment of Community Medicine, Maulana Azad Medical College, New Delhi, India.
Ashwani KhannaChest Clinic (TB), Lok Nayak Hospital, New Delhi, India.
Shivani ChandraOffice of the WHO Representative to India, WHO Country Office, New Delhi, India.
Saurav BasuDepartment of Community Medicine, Maulana Azad Medical College, New Delhi, India.
Kamal K ChopraNew Delhi Tuberculosis Centre, Delhi, India.
Neeta SinglaDepartment of Epidemiology & Public Health, National Institute of Tuberculosis & Respiratory Diseases, Delhi, India.
Neeti BabbarDelhi State TB Programme, State TB Cell, Delhi, India.
Charu KohliDepartment of Community Medicine, North DMC Medical College & Hindu Rao Hospital, Delhi, India.

Funding

World Health Organization 001
6 · The paper itself

Abstract

Background & objectives: The increase in the burden of multidrug-resistant tuberculosis (MDR-TB) is a matter of grave concern. The present study was undertaken to describe MDR-TB treatment outcome trends in Delhi and their epidemiological correlates, to assess the adequacy of treatment records and to also generate evidence towards influencing and improving practices related to the MDR-TB control programme. Methods: A retrospective record-based study (2009-2014) was conducted in three major drug resistance TB treatment centres of Delhi. Treatment outcomes and adverse effects were extracted from the existing programme records including patients' treatment cards and laboratory registers. Results: A total of 2958 MDR-TB patients were identified from the treatment cards, of whom 1749 (59.12%) were males. The mean (±standard deviation) age was 30.56±13.5 years. Favourable treatment outcomes were reported in 1371 (53.28%) patients, but they showed a declining trend during the period of observation. On binomial logistic regression analysis, patients with age ≥35 yr, male sex and undernourishment (body mass index <18.5) at the time of treatment initiation had a significantly increased likelihood of unfavourable MDR-TB treatment outcome (P <0.001). Interpretation & conclusions: The study showed an increasing burden of MDR-TB patients, especially in the young population with increased risk of transmission posing a major challenge in achieving TB elimination targets.

Indexed as

Mycobacterium tuberculosisTuberculosis, Multidrug-ResistantAdolescentAdultAntitubercular AgentsFemaleHumansIndiaMaleRetrospective StudiesTreatment OutcomeYoung AdultAntitubercular AgentsDrug resistanceIndiaMDR-TBtreatment outcomeXDR-TB

Identifiers

PMID32719234
PMCPMC7602924

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.